EUR 28.3
(1.51%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 591.07 Million SEK | 80.14% |
2022 | 29.34 Million SEK | 42.29% |
2021 | 20.62 Million SEK | 14.57% |
2020 | 17.99 Million SEK | 21.65% |
2019 | 14.79 Million EUR | 55.19% |
2018 | 9.53 Million EUR | -27.51% |
2017 | 13.15 Million EUR | 20.48% |
2016 | 10.91 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 219.79 Million EUR | 19.18% |
2024 Q3 | 237.5 Million SEK | 8.06% |
2024 Q1 | 15.96 Million SEK | 6.76% |
2023 FY | 52.85 Million SEK | 80.14% |
2023 Q4 | 15.44 Million SEK | 13.17% |
2023 Q1 | 10.59 Million SEK | 15.03% |
2023 Q2 | 11.87 Million SEK | 12.12% |
2023 Q3 | 13.64 Million SEK | 14.89% |
2022 Q2 | 6.93 Million EUR | 8.94% |
2022 FY | 29.34 Million SEK | 42.29% |
2022 Q4 | 9.21 Million EUR | 18.92% |
2022 Q3 | 7.74 Million EUR | 11.67% |
2022 Q1 | 6.36 Million EUR | 7.05% |
2021 Q4 | 5.94 Million EUR | 0.0% |
2021 FY | 20.62 Million SEK | 14.57% |
2020 FY | 17.99 Million SEK | 21.65% |
2019 FY | 14.79 Million EUR | 55.19% |
2018 FY | 9.53 Million EUR | -27.51% |
2017 FY | 13.15 Million EUR | 20.48% |
2016 FY | 10.91 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 898.6 Million EUR | 34.223% |
Carl Zeiss Meditec AG | 2.08 Billion EUR | 71.709% |
Fielmann Aktiengesellschaft | 1.96 Billion EUR | 69.982% |
Gerresheimer AG | 1.99 Billion EUR | 70.305% |
Sartorius Aktiengesellschaft | 3.39 Billion EUR | 82.593% |
Sartorius Aktiengesellschaft | 3.39 Billion EUR | 82.593% |